verbio Vereinigte BioEnergie (VBK) AI Stock Analysis

• Market Cap: €846.14M
• Dividend Yield: 1.3%
• Average Volume (3M): 165.84K
• Price to Earnings (P/E): ―
• Beta (1Y): 1.17
• Revenue Growth: -4.72%
• EPS Growth: -789.75%
• Country: DE
• Employees: 1,521
• Sector: Energy
• Sector Strength: 52
• Industry: Chemicals - Specialty
• EPS (TTM): -1.52
• Shares Outstanding: 63,715,480
• 10 Day Avg. Volume: 196,028
• 30 Day Avg. Volume: 165,844
• PEG Ratio: <0.01
• Price to Book (P/B): 1.04
• Price to Sales (P/S): 0.49
• P/FCF Ratio: -6.59
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €12.40
• Price Target Upside: -19.38% Downside
• Rating Consensus: Hold
• Number of Analyst Covering: 2

• Rating: 57 Neutral
• Price Target: €14.00 ▼(-8.97% Downside)

The overall stock score is primarily impacted by the company's financial struggles, including declining profitability and cash flow issues. Despite bullish technical indicators, the overbought status and negative valuation metrics present risks. The earnings call provided some optimism for future regulatory support, but current challenges remain significant.

Positive Factors

Regulatory Environment

The introduction of stricter biofuel regulations in Germany could create a more favorable market environment, supporting Verbio's strategic focus on sustainability and potentially boosting demand for its biofuel products.

Strategic Expansion

Enhanced plant utilization in North America, especially in the biodiesel sector, indicates successful strategic expansion efforts, which could lead to sustained EBITDA growth and increased market share in the region.

Production Capacity

High production capacity and utilization rates demonstrate operational efficiency and the ability to meet demand, supporting revenue stability and growth in the bioenergy sector.

Negative Factors

Declining Profitability

The sharp decline in gross profit margin reflects operational challenges and cost pressures, which could hinder long-term profitability and financial health if not addressed effectively.

Cash Flow Issues

Negative free cash flow indicates struggles in cash generation, potentially limiting the company's ability to invest in growth opportunities and maintain financial flexibility.

EBITDA Decline

The significant decline in EBITDA highlights market challenges and operational inefficiencies, which could impact the company's ability to sustain growth and profitability in the competitive bioenergy sector.

verbio Vereinigte BioEnergie Business Overview & Revenue Model

Company Description

Verbio Vereinigte BioEnergie (VBK) is a leading German company specializing in the production of renewable energy and biofuels. Operating primarily in the sectors of bioenergy and sustainable agriculture, VBK focuses on the development and manufacture of high-quality biodiesel, biomethane, and other bio-based products. The company is committed to promoting environmentally friendly energy solutions and reducing greenhouse gas emissions through innovative technologies and sustainable practices.

How the Company Makes Money

VBK generates revenue primarily through the sale of renewable energy products, including biodiesel and biomethane, which are sold to various industries and consumers. The company benefits from government subsidies and incentives aimed at promoting renewable energy use, which enhances its profitability. Additionally, VBK has established key partnerships with agricultural producers for the sourcing of raw materials, such as organic waste and crops, which further supports its production processes. The diversification of its biofuel offerings and investment in advanced technologies also contribute to its revenue streams, positioning VBK as a competitive player in the bioenergy market.

verbio Vereinigte BioEnergie Financial Statement Overview

Summary

The company is facing significant financial challenges with declining profitability and inconsistent revenue growth. The balance sheet remains stable but shows stress with negative returns on equity. Cash flow issues are evident, with negative free cash flow and reduced cash generation efficiency.

Income Statement

The income statement shows a concerning trend with declining profitability. The company has experienced a significant drop in gross profit margin from 33.7% in 2021 to 2.3% in 2025. Net profit margin has also turned negative, indicating losses. Revenue growth has been inconsistent, with a recent positive growth of 6.1% in 2025 after previous declines. The EBIT and EBITDA margins have deteriorated significantly, reflecting operational challenges.

Balance Sheet

The balance sheet remains relatively stable with a manageable debt-to-equity ratio of 0.36 in 2025, up from 0.06 in 2021. However, the return on equity has turned negative, indicating inefficiencies in generating returns from equity. The equity ratio remains healthy, suggesting a solid capital structure despite the recent performance issues.

Cash Flow

Cash flow analysis reveals challenges, with free cash flow turning negative in recent years. The operating cash flow to net income ratio has decreased, indicating reduced cash generation efficiency. The free cash flow to net income ratio is negative, highlighting cash flow struggles relative to earnings.

Breakdown	TTM	Dec 2025	Dec 2024	Dec 2023	Dec 2022	Dec 2021
Income Statement
Total Revenue	1.58B	1.58B	1.67B	1.97B	1.81B	1.03B
Gross Profit	102.56M	37.12M	292.45M	381.91M	626.92M	271.64M
EBITDA	15.40M	-54.41M	122.92M	242.68M	494.81M	166.48M
Net Income	-138.01M	-138.01M	19.96M	132.02M	315.63M	93.20M
Balance Sheet
Total Assets	1.30B	1.30B	1.38B	1.30B	1.13B	678.62M
Cash, Cash Equivalents and Short-Term Investments	64.41M	64.41M	126.70M	170.31M	300.50M	105.34M
Total Debt	268.86M	268.86M	194.20M	189.97M	49.39M	46.48M
Total Liabilities	527.61M	527.61M	449.54M	385.36M	310.16M	168.75M
Stockholders Equity	746.29M	746.29M	925.67M	909.47M	816.23M	507.85M
Cash Flow
Free Cash Flow	-118.66M	-117.96M	-54.38M	-177.12M	210.15M	49.90M
Operating Cash Flow	13.88M	13.88M	116.78M	26.09M	325.03M	117.18M
Investing Cash Flow	-120.06M	-120.06M	-144.90M	-266.43M	-113.62M	-46.56M
Financing Cash Flow	49.88M	49.88M	-19.53M	112.21M	-18.48M	-18.76M

verbio Vereinigte BioEnergie Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 15.38
• 50DMA: Positive
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For DE:VBK, the sentiment is Positive. The current price of 15.38 is above the 20-day moving average (MA) of 14.16, above the 50-day MA of 12.06, and above the 200-day MA of 10.61, indicating a bullish trend. The MACD of 1.12 indicates Negative momentum. The RSI at 68.66 is Neutral, neither overbought nor oversold. The STOCH value of 67.83 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for DE:VBK.

verbio Vereinigte BioEnergie Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
ACT	―	€1.70B	29.16	29.12%	1.08%	1.03%	25.48%
EVK	―	€6.77B	15.97	4.87%	8.05%	-2.62%	―
Sector *	―	$15.17B	7.61	4.09%	5.20%	3.87%	-62.32%
WCH	―	$3.40B	14.11	―	3.65%	-10.63%	-23.15%
VBK	―	€846.14M	―	-16.51%	1.30%	-4.72%	-789.75%
1COV	―	€10.86B	-29.42	-5.90%	―	-1.98%	-16.31%
LXS	―	$1.78B	―	-3.72%	0.48%	-2.75%	83.47%

verbio Vereinigte BioEnergie Corporate Events

Verbio Earnings Call: Strategic Wins Amid Financial Struggles

The recent earnings call for Verbio Vereinigte BioEnergie presented a mixed sentiment, with strategic achievements and regulatory advancements being overshadowed by significant financial challenges. While the company expressed optimism about future regulatory support and strategic expansions, current financial struggles, particularly in Europe, remain a substantial concern.